Synmosa Biopharma Market Cap

Synmosa Biopharma has a market cap or net worth of 15.00 billion as of May 13, 2025. Its market cap has decreased by -0.47% in one year.

Market Cap

15.00B

Enterprise Value

16.86B

Revenue

5.55B

Ranking

n/a

PE Ratio

20.34

Stock Price

32.95

Market Cap Chart

Since May 8, 2006, Synmosa Biopharma's market cap has increased from 583.47M to 15.00B, an increase of 2,470.88%. That is a compound annual growth rate of 18.61%.

Market Cap History

Date	Market Cap	% Change
May 12, 2025	15.00B	3.46%
Dec 31, 2024	14.50B	-1.41%
Dec 29, 2023	14.71B	-8.20%
Dec 30, 2022	16.02B	128.36%
Dec 30, 2021	7.02B	2.96%
Dec 31, 2020	6.81B	20.87%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
PharmaEssentia	166.19B
Caliway Biopharmaceuticals	115.80B
Bora Pharmaceuticals Co., LTD.	73.49B
Lotus Pharmaceutical	60.56B
Polaris Group	33.16B
Oneness Biotech	29.46B
Pegavision	27.14B
Lumosa Therapeutics	26.85B

Market Cap Rankings